Yenidoğan Döneminde Supraventriküler Taşikardi ve Tedavi Yaklaşımları

Osman Öztekin; Salih Kalay; Gönül Tezel; Murat Çiftçi; Mustafa Akçakuş; Nihal Oygür

doi:10.12956/tjpd.2015.172

Research Article

Turk J Pediatr Dis 2016; 10(1): 31-34.

PDF

Neonatal Period Supraventricular Tachycardia and Treatment Approaches in the

Authors

Osman Öztekin

Salih Kalay

Gönül Tezel

Murat Çiftçi

Mustafa Akçakuş

Nihal Oygür

Affiliations

Turk J Pediatr Dis 2016; 10(1): 31-34. DOI: 10.12956/tjpd.2015.172

Published: April 1, 2016

Abstract

Objective: Retrospective analysis for treatment approaches of supraventricular tachycardia (SVT) during the prenatal and postnatal period.

Material and Methods: Fifteen new-born patients who were followed with supraventricular tachycardia were analysed retrospectively. Patients were divided into two groups as prenatal onset (PreOSVT) and postnatal onset (PostOSVT).

Results: Eight patients (53%) were diagnosed with PreOSVT and 7 patients (47%) were diagnosed with PostOSVT. It was observed that, 0.1 mg/kg dose of adenosine was used in all patient as a fi rst line treatment, 4 antiarrhythmic agents (amiodarone, propranolol, adenosine, digoxin) were used in 4 patients, 5 antiarrhythmic agents (amiodarone, propranolol, adenosine, digoxin, propafenone) were used in one patient and the cardioversion procedure was used in 2 patients with PreOSVT and one patient with PostOSVT.

Conclusion: Treatment approaches and the results are similar in patients with PreOSVT and PostOSVT

Keywords: Supraventricular tachycardia, Treatment, Newborn

References

Van Hare GF. Neonatal arrhythmias. In: Fanaroff AA, Martin RJ (eds). Neonatal-Perinatal Medicine Diseases of the Fetus and Infant. Vol: 2, 9th ed. St. Louis: Mosby, 2011:1277-89.
Hoffman TM, Wernovsky G, Wieand TS, Cohen MI, Jennings AC, Vetter VL, et al. The incidence of arrhythmias in a pediatric intensive car e unit. Pediatr Cardiol 2002;23:598-604.
Tavera MC, Bassareo PP, Neroni P, Follese C, Manca D, Montis S, et al. Supraventricular tachycardia in neonates: Antiarrhythmic drug choice dilemma. J Matern Fetal Neonatal Med 2011;24:541- 4.
Garson A Jr, Gillette PC, McNamara DG. Supraventricular tachycardia in children: Clinical features, response to treatment, and long-term follow-up in 217 patients. J Pediatr 1981;98: 875-82.
Kleinman CS, Neghme RA. Cardiac arrhythmias in the human fetus. Pediatr Cardiol 2004;25:234-51.
Rasiah SV, Ewer AK, Miller P, Kilby MD. Prenatal diagnosis, management and outcome of fetal dysrhythmia: A tertiary fetal medicine centre experience over an eight-year period. Fetal Diagn Ther 2011;30:122-7.
Wren C. Cardiac arrhythmias in the fetus and newborn. Semin Fetal Neonatal Med 2006;11:182-90.
Oudijk MA, Visser GH, Meijboom EJ. Fetal tachyarrhythmia—part I: Diagnosis. Indian Pacing Electrophysiol J 2004;4:104-13.
Kantoch MJ. Supraventricular tachycardia in children. Indian J Pediatr 2005;72:609-19
Manole MD, Saladino RA. Emergency department management of the pediatric patient with supraventricular tachycardia. Pediatr Emerg Care 2007;23:176-85.
Balaguer Gargallo M, Jordán García I, Caritg Bosch J, Cambra Lasaosa FJ, Prada Hermogenes F, Palomaque Rico A. Supraventricular tachycardia in infants and children. An Pediatr 2007; 67:133-8.
Etheridge SP, Janet C, Steven J. Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants. Am Heart J 2001;141:105-10.
Abid L, Trabelsi I, Maazoun Y, Krichène S, Laroussi L, Hammami R, et al. Supraventricular tachycardia in infants. Ann Cardiol Angeiol 2011;60:141-7.
Park MK. Cardiac arrhytmias. In: Park MK (ed). Pediatric Cardiology for Practitioners. 5th ed. Philedelphia: Mosby Elsevier Pres, 2008: 417-44.
Bodegas A, Cabrera A, Sarrionaindia MJ, Idígoras G, Rumoroso JR, Pérez García P, et al. Propafenone effi cacy in preventing supraventricular tachycardia in childhood. Rev Esp Cardiol 1994;47:86-91.
Kishore AG, Camm AJ. Guidelines for the use of propafenone in treating supraventricular arrhythmias. Drugs 1995;50:250-62.
Stephanie BW, Wernovsky G. Arrhythmias. In: Cloherty John P, Eichenwald Eric C, Stark Ann R (eds). Manual of Neonatal Care, 6th ed. Philadelphia: Lippincott Williams and Wilkins, 2008:429- 35.

Copyright and license

Copyright © 2016 The Author(s). This is an open access article distributed under the Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite

Öztekin O, Kalay S, Tezel G, Çiftçi M, Akçakuş M, Oygür N. Neonatal Period Supraventricular Tachycardia and Treatment Approaches in the. Turk J Pediatr Dis [Internet]. 2016 Apr. 1 [cited 2025 Aug. 23];10(1):31-4. Available from: https://turkjpediatrdis.org/article/view/412

Download citation

[ref1] Van Hare GF. Neonatal arrhythmias. In: Fanaroff AA, Martin RJ (eds). Neonatal-Perinatal Medicine Diseases of the Fetus and Infant. Vol: 2, 9th ed. St. Louis: Mosby, 2011:1277-89.

[ref2] Hoffman TM, Wernovsky G, Wieand TS, Cohen MI, Jennings AC, Vetter VL, et al. The incidence of arrhythmias in a pediatric intensive car e unit. Pediatr Cardiol 2002;23:598-604.

[ref3] Tavera MC, Bassareo PP, Neroni P, Follese C, Manca D, Montis S, et al. Supraventricular tachycardia in neonates: Antiarrhythmic drug choice dilemma. J Matern Fetal Neonatal Med 2011;24:541- 4.

[ref4] Garson A Jr, Gillette PC, McNamara DG. Supraventricular tachycardia in children: Clinical features, response to treatment, and long-term follow-up in 217 patients. J Pediatr 1981;98: 875-82.

[ref5] Kleinman CS, Neghme RA. Cardiac arrhythmias in the human fetus. Pediatr Cardiol 2004;25:234-51.

[ref6] Rasiah SV, Ewer AK, Miller P, Kilby MD. Prenatal diagnosis, management and outcome of fetal dysrhythmia: A tertiary fetal medicine centre experience over an eight-year period. Fetal Diagn Ther 2011;30:122-7.

[ref7] Wren C. Cardiac arrhythmias in the fetus and newborn. Semin Fetal Neonatal Med 2006;11:182-90.

[ref8] Oudijk MA, Visser GH, Meijboom EJ. Fetal tachyarrhythmia—part I: Diagnosis. Indian Pacing Electrophysiol J 2004;4:104-13.

[ref9] Kantoch MJ. Supraventricular tachycardia in children. Indian J Pediatr 2005;72:609-19

[ref10] Manole MD, Saladino RA. Emergency department management of the pediatric patient with supraventricular tachycardia. Pediatr Emerg Care 2007;23:176-85.

[ref11] Balaguer Gargallo M, Jordán García I, Caritg Bosch J, Cambra Lasaosa FJ, Prada Hermogenes F, Palomaque Rico A. Supraventricular tachycardia in infants and children. An Pediatr 2007; 67:133-8.

[ref12] Etheridge SP, Janet C, Steven J. Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants. Am Heart J 2001;141:105-10.

[ref13] Abid L, Trabelsi I, Maazoun Y, Krichène S, Laroussi L, Hammami R, et al. Supraventricular tachycardia in infants. Ann Cardiol Angeiol 2011;60:141-7.

[ref14] Park MK. Cardiac arrhytmias. In: Park MK (ed). Pediatric Cardiology for Practitioners. 5th ed. Philedelphia: Mosby Elsevier Pres, 2008: 417-44.

[ref15] Bodegas A, Cabrera A, Sarrionaindia MJ, Idígoras G, Rumoroso JR, Pérez García P, et al. Propafenone effi cacy in preventing supraventricular tachycardia in childhood. Rev Esp Cardiol 1994;47:86-91.

[ref16] Kishore AG, Camm AJ. Guidelines for the use of propafenone in treating supraventricular arrhythmias. Drugs 1995;50:250-62.

[ref17] Stephanie BW, Wernovsky G. Arrhythmias. In: Cloherty John P, Eichenwald Eric C, Stark Ann R (eds). Manual of Neonatal Care, 6th ed. Philadelphia: Lippincott Williams and Wilkins, 2008:429- 35.

Türkiye Çocuk Hastalıkları Dergisi